Insider Buying: Crescita Therapeutics Inc. (CTX) Director Buys 86,200 Shares of Stock
Crescita Therapeutics Inc. (TSE:CTX) Director Daniel Chicoine acquired 86,200 shares of the stock in a transaction on Tuesday, December 5th. The shares were bought at an average price of C$0.58 per share, for a total transaction of C$49,996.00.
Crescita Therapeutics Inc. (TSE:CTX) traded up C$0.01 during trading on Thursday, reaching C$0.60. The company’s stock had a trading volume of 8,222 shares, compared to its average volume of 13,875. Crescita Therapeutics Inc. has a 12-month low of C$0.52 and a 12-month high of C$1.54.
TRADEMARK VIOLATION NOTICE: “Insider Buying: Crescita Therapeutics Inc. (CTX) Director Buys 86,200 Shares of Stock” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/12/07/insider-buying-crescita-therapeutics-inc-ctx-director-buys-86200-shares-of-stock.html.
About Crescita Therapeutics
Crescita Therapeutics Inc, a dermatology company, provides over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. It owns various proprietary drug delivery platforms, including DuraPeel and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin.
Receive News & Ratings for Crescita Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.